Lauxera Capital Partners invests €10m in German Medtech software company Matrix Requirements.
This initial investment allows Lauxera to take a majority stake and support active business development efforts alongside an ambitious product development roadmap.
Matrix Requirements helps medical device companies meet their growing need for quality and regulatory compliance in a world where the lines between medical devices and software are blurring. Matrix Requirements is a perfect fit for medical device companies developing complex products, often with significant software-dependent features.
Wolfgang Huber and Yves Berquin, co-founders of Matrix Requirements, said: “We are delighted to partner with Lauxera to accelerate the development of Matrix Requirements and our products. We share the vision of continuing to offer the best solutions to make Matrix Requirements a global leader in its industry. This transaction provides the company with the means to significantly accelerate its growth by adding to the team of which we are very proud. Lauxera’s entrepreneurial culture, skills and experience make it an ideal partner. We are looking forward to this new step in our development.”
Wolfgang Huber and Yves Berquin entitled E-Spring as the sole financial advisor to conduct this operation.
About Matrix Requirements
Founded in 2014 by Wolfgang Huber and Yves Berquin, Matrix Requirements supports the R&D, Regulatory Affairs and Quality departments of MedTech companies by providing specialized digital tools for medical device design, traceability, quality management and regulatory compliance. Since its inception, the consistently profitable company has achieved an average annual recurring revenue growth rate of 45% primarily targeting a market of over 90,000 medtech companies in Europe and the United States.
About Lauxera Capital Partners
Founded in January 2020, Lauxera Capital Partners is an independent asset management company based in France (Paris) and in the United States (San Francisco). Lauxera is a healthcare specialist investor working to promote the growth of European HealthTech companies. Led by a team of life sciences business builders and professional healthcare investors with more than 50 years’ experience, Lauxera aims to support the international commercial expansion of Europe’s most promising HealthTech innovations.
For more information about the transaction, please see the official press releases on https://lauxera.com/news and https://matrixreq.com/news